L Ekselius1, L Von Knorring. 1. Department of Neuroscience, Psychiatry, University Hospital, Uppsala, Sweden.
Abstract
BACKGROUND: Recent studies indicate that selective serotonin re-uptake inhibitors (SSRIs) reduce the symptoms accompanying personality disorders and modulate a normal personality. AIMS: To examine the effect of two SSRIs, sertraline and citalopram, on personality traits in major depressed patients. METHOD:Personality traits were evaluated at baseline and after six months using the Karolinska Scales of Personality (KSP). RESULTS: After treatment, significant changes in the direction of normalisation were seen in all scales. To determine whether the observed changes could be explained by improved depressive symptoms, multiple stepwise regressions with the separate KSP as dependent variables were performed. Improvements in depressive symptoms only accounted for 0-8.4% of the observed variance. CONCLUSIONS: In depressed patients treated with SSRIs significant effects are seen on personality traits measured by the KSP.
RCT Entities:
BACKGROUND: Recent studies indicate that selective serotonin re-uptake inhibitors (SSRIs) reduce the symptoms accompanying personality disorders and modulate a normal personality. AIMS: To examine the effect of two SSRIs, sertraline and citalopram, on personality traits in major depressedpatients. METHOD: Personality traits were evaluated at baseline and after six months using the Karolinska Scales of Personality (KSP). RESULTS: After treatment, significant changes in the direction of normalisation were seen in all scales. To determine whether the observed changes could be explained by improved depressive symptoms, multiple stepwise regressions with the separate KSP as dependent variables were performed. Improvements in depressive symptoms only accounted for 0-8.4% of the observed variance. CONCLUSIONS: In depressedpatients treated with SSRIs significant effects are seen on personality traits measured by the KSP.
Authors: Boadie W Dunlop; Jared A DeFife; Lauren Marx; Steven J Garlow; Charles B Nemeroff; Scott O Lilienfeld Journal: Int Clin Psychopharmacol Date: 2011-11 Impact factor: 1.659
Authors: Rianne M Blom; Jack F Samuels; Mark A Riddle; O Joseph Bienvenu; Marco A Grados; Irving M Reti; William W Eaton; Kung-Yee Liang; Gerald Nestadt Journal: J Psychiatr Res Date: 2011-03-29 Impact factor: 4.791
Authors: Ulla Knorr; Maj Vinberg; Erik Lykke Mortensen; Per Winkel; Christian Gluud; Jørn Wetterslev; Ulrik Gether; Lars Vedel Kessing Journal: PLoS One Date: 2012-02-29 Impact factor: 3.240